Dagmar Hess

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer

Rodryg Ramlau, Élisabeth Quoix, Janusz Rolski et al. · Journal of Thoracic Oncology · 2008 · 202 citations

Cancer Immunosurveillance, Medicine, Immunology +7

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Diana Crivellari, Olivia Pagani, Andrea Veronesi et al. · Annals of Oncology · 2001 · 150 citations · Full text

Neuro-oncology, Advanced Breast Cancer, Breast Oncology +7

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors

Volker Lennerz, Elisa Gallerani, Cristiana Sessa et al. · Cancer Immunology Immunotherapy · 2014 · 125 citations · Full text

Vaccination, Tumor Immunology, Vaccine Development +11

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3weeks in solid tumours: An ECSG/EORTC study

Alain Ravaud, Thomas Cerny, C. Terret et al. · European Journal of Cancer · 2005 · 103 citations

Oncology, Ecsg/eortc Study, Pharmacology +9